MXPA05005915A - Soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas. - Google Patents

Soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas.

Info

Publication number
MXPA05005915A
MXPA05005915A MXPA05005915A MXPA05005915A MXPA05005915A MX PA05005915 A MXPA05005915 A MX PA05005915A MX PA05005915 A MXPA05005915 A MX PA05005915A MX PA05005915 A MXPA05005915 A MX PA05005915A MX PA05005915 A MXPA05005915 A MX PA05005915A
Authority
MX
Mexico
Prior art keywords
pka
activity
low
obtaining
human albumin
Prior art date
Application number
MXPA05005915A
Other languages
English (en)
Inventor
Nuria Hosta Mateu
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34072931&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA05005915(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of MXPA05005915A publication Critical patent/MXPA05005915A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invencion da a conocer una solucion de albumina purificada de origen humano con baja actividad de Activador de Precalicreina (PKA) y estabilidad en el tiempo, caracterizada por presentar un contenido de Antitrombina igual o mayor a 0,03 mg/gr de albumina, y un procedimiento de obtencion de la misma basado en la extraccion parcial de la Antitrombina durante el fraccionamiento del plasma humano.
MXPA05005915A 2004-07-26 2005-06-02 Soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas. MXPA05005915A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200401830A ES2221817B1 (es) 2004-07-26 2004-07-26 "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas".

Publications (1)

Publication Number Publication Date
MXPA05005915A true MXPA05005915A (es) 2006-01-30

Family

ID=34072931

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05005915A MXPA05005915A (es) 2004-07-26 2005-06-02 Soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas.

Country Status (10)

Country Link
US (2) US7332577B2 (es)
EP (1) EP1656954B2 (es)
JP (1) JP4584788B2 (es)
AU (1) AU2005202654B2 (es)
BR (1) BRPI0502744B8 (es)
DE (1) DE602005003426T3 (es)
ES (2) ES2221817B1 (es)
MX (1) MXPA05005915A (es)
PL (1) PL1656954T4 (es)
PT (1) PT1656954E (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101702334B1 (ko) * 2015-04-28 2017-02-06 동양피스톤 주식회사 피스톤용 냉각 튜브, 링 캐리어 어셈블리, 피스톤 및 이를 이용한 피스톤 제조 방법
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597693B2 (ja) * 1978-01-07 1984-02-20 株式会社ミドリ十字 抗トロンビン製剤及びその製法
US4251510A (en) * 1979-08-15 1981-02-17 Cutter Laboratories, Inc. Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
US4378346A (en) * 1979-08-15 1983-03-29 Tankersley Donald L Intravenously injectable solution of plasma protein fraction free from bradykinin, kininogen and prekallikrein activators and processes for its production
DE3612137A1 (de) * 1986-04-10 1987-10-15 Biotest Pharma Gmbh Steriles plasmaaustauschmittel
DE3622642A1 (de) * 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
FR2610633B1 (fr) * 1987-02-05 1992-09-18 Lille Transfusion Sanguine Procede d'obtention d'un concentre d'a 1-antitrypsine a partir de plasma humain et son utilisation a titre de medicament
AT391810B (de) * 1988-02-26 1990-12-10 Immuno Ag Verwendung von chymotrypsin zum unwirksammachen des praekallikrein-aktivators
FR2648048B1 (fr) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine Procede de preparation de solutions d'albumine purifiee
ES2103236B1 (es) * 1996-01-30 1998-04-16 Grifols Grupo Sa Albumina humana terapeutica con baja capacidad para la fijacion de aluminio.
WO1997031947A1 (en) * 1996-02-29 1997-09-04 Delta Biotechnology Limited High purity albumin production process
WO2000056768A2 (en) * 1999-03-19 2000-09-28 Bayer Corporation Chromatographic albumin process
ES2261977T3 (es) * 2002-11-25 2006-11-16 Octapharma Ag Fraccion de albumina derivada de plasma empobrecido en precalicreina.

Also Published As

Publication number Publication date
ES2294664T5 (es) 2021-11-30
AU2005202654A1 (en) 2006-02-09
EP1656954B1 (en) 2007-11-21
BRPI0502744B1 (pt) 2019-02-26
ES2294664T3 (es) 2008-04-01
BRPI0502744A (pt) 2006-05-02
BRPI0502744B8 (pt) 2021-05-25
US7332577B2 (en) 2008-02-19
PT1656954E (pt) 2008-02-14
US20060020117A1 (en) 2006-01-26
DE602005003426T2 (de) 2008-10-02
ES2221817B1 (es) 2005-10-01
PL1656954T4 (pl) 2008-08-29
US8084580B2 (en) 2011-12-27
DE602005003426T3 (de) 2021-09-02
EP1656954A1 (en) 2006-05-17
US20070161781A1 (en) 2007-07-12
AU2005202654B2 (en) 2007-04-05
JP2006036771A (ja) 2006-02-09
DE602005003426D1 (de) 2008-01-03
EP1656954B2 (en) 2021-04-28
ES2221817A1 (es) 2005-01-01
PL1656954T3 (pl) 2008-04-30
JP4584788B2 (ja) 2010-11-24

Similar Documents

Publication Publication Date Title
HRP20041071A2 (en) Methods of treating hepatitis
RS91004A (en) Methods of treating ileus
TW200633992A (en) Biaryloxymethylarenecarboxylic acids
MY138708A (en) Biaryloxymethylarenecarboxylic acids
DE60110054D1 (en) Cardioprotektive phosphonate
IS7817A (is) Fenýlalanín afleiður sem dípeptidýl peptíðasa hindrar til að meðhöndla eða fyrirbyggja sykursýki.
IN2015DN01010A (es)
HK1102366A1 (en) Factor ixa for the treatment of bleeding disorders
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
MX2007002470A (es) Fenilaminotiazoles sustituidos y su uso.
WO2009020643A3 (en) Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue
UA86570C2 (ru) Способ лечения некротизирующего энтероколита
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
GB0216001D0 (en) Process and composition
HK1112228A1 (en) Substituted azachinzolines having an antiviral action
IL195907A0 (en) Protein-binding methotrexate derivatives, and medicaments containing the same
MXPA05005915A (es) Soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas.
IL175358A0 (en) 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
TW200603791A (en) Compounds and compositions as cathepsin S inhibitors
IL165996A0 (en) Novel thiophene acyl hydrazino derivatives method for preparing same use thereof as medicines pharmaceutical compositions and novel use
UA92908C2 (ru) Соединения, производные от 5-тиоксилозы, и их терапевтическое применение
IL175357A0 (en) 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
RS95204A (en) Combination for the treatment of airway disorders
MD2322F1 (en) Method of decreasing the arterial hypertension, induced by the renin-angiotensin-aldosterone system superactivity
WO2004002486A3 (en) Ciprofloxacin hci

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration